Clarify the Role of Mounjaro for Type 2 Diabetes

You’ll hear buzz about new injectable Mounjaro (tirzepatide)...the first “twincretin” for type 2 diabetes.

Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist...but it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works.

GLP-1 and GIP stimulate insulin release, increase satiety, and decrease glucose production.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote